The stringent response (SR) is a regulatory mechanism that enables bacteria to adapt to nutrient stress through the production of the alarmone (p)ppGpp. The aim of the current study was to understand how the SR affects the antifungal (AF) activity of Pseudomonas chlororaphis PA23. Two SR mutants were generated, PA23relA and PA23relAspoT, that no longer produced (p)ppGpp. Both mutants exhibited increased inhibition of Sclerotinia sclerotiorum in vitro and elevated pyrrolnitrin (PRN), lipase and protease production. Phenazine (PHZ) levels, on the other hand, remained unchanged. Through transcriptional fusion analysis we discovered that prnA-lacZ (PRN) activity was increased in the SR mutants, whereas phzA-lacZ (PHZ) activity was equal to that of the wild-type. We also examined how the sigma factor RpoS impacts PA23-mediated antagonism. Similar to the SR mutants, an rpoS mutant of PA23, called PA23rpoS, exhibited enhanced AF activity in vitro and increased expression of PRN, protease and lipase. However, PHZ production and expression of phzA-lacZ were dramatically reduced. Consistent with what has been reported for other bacteria, the SR exerted positive control over rpoS expression. In addition, providing rpoS in trans restored the SR phenotype to that of the wild-type. Collectively, our findings indicate that this global stress response impacts production of PA23 AF compounds via regulation of rpoS transcription and has an overall negative influence on S. sclerotiorum antagonism.
INTRODUCTION
When applied as a foliar spray, Pseudomonas chlororaphis PA23 is able to protect canola from sclerotinia stem rot caused by the fungal pathogen Sclerotinia sclerotiorum (Lib.) (Savchuk & Fernando, 2004) . Because the phyllosphere is a nutrient-poor environment, PA23 must employ strategies to cope with low carbon and energy availability. The stringent response (SR) is a mechanism that enables bacteria to alter their metabolism in response to nutrient deprivation, shifting from a reproductive mode to one that promotes survival. This adaptation is accomplished through intracellular accumulation of the nucleotides guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp), collectively known as (p)ppGpp. In Gram-negative bacteria, (p)ppGpp is synthesized by a RelA synthetase, while hydrolysis of this metabolite is mediated by a second enzyme called SpoT (Potrykus & Cashel, 2008) . SpoT is considered bifunctional since it is capable of (p)ppGpp synthesis under specific environmental conditions (Potrykus & Cashel, 2008 , and references therein). (p)ppGpp binds to RNA polymerase near its catalytic site, leading to increased transcription of certain genes, for instance those involved in amino acid biosynthesis (Potrykus & Cashel, 2008) . At the same time, the conformation change induced by (p)ppGpp binding causes decreased transcription at other loci, as observed with the tRNA and rRNA genes (Potrykus & Cashel, 2008) . In this manner, the SR enables bacteria to adapt to nutrient deprivation by mediating global changes in gene expression.
As with many biocontrol pseudomonads, PA23 attributes its antifungal (AF) activity to secondary metabolite production (Poritsanos et al., 2006; Selin et al., 2010) . These metabolites are synthesized at the onset of stationary phase and are regulated at both the transcriptional and post-transcriptional level. The Gac two-component system is situated at the top of the regulatory cascade and comprises the sensor kinase GacS and its cognate response regulator GacA (Heeb & Haas, 2001 ). In several pseudomonads, including PA23, a mutation in either gacA or gacS leads to a lack of fungal inhibition (Heeb & Haas, 2001; Poritsanos et al., 2006) . The alternative sigma factor RpoS has also been implicated in secondary metabolite production; however, regulation by RpoS varies depending on the producing organism and the antibiotic in question. For example, an rpoS mutation in Pseudomonas fluorescens Pf-5 resulted in enhanced production of the antibiotics pyoluteorin and 2,4-diacetylphloroglucinol but abolished pyrrolnitrin (PRN) expression (Sarniguet et al., 1995; Whistler et al., 1998) , while the same mutation in P. chlororaphis PCL1391 caused a decrease in phenazine-1-carboxamide production compared with the wild type (Girard et al., 2006a) . In addition, several global and pathway-specific regulators have been identified that play a role in regulating biocontrol traits of Pseudomonas species (Haas & Défago, 2005) .
PA23 produces an arsenal of factors, including PRN, phenazine (PHZ), hydrogen cyanide (HCN), lipase and protease, that likely contribute to fungal antagonism (Poritsanos et al., 2006) . In a previous study, it was discovered that PRN plays a more important role than PHZ in controlling S. sclerotiorum infection on canola (Selin et al., 2010) . With the exception of Pseudomonas sp. MIS38 (Washio et al., 2010) , there is little known about the effect of the SR on the AF activity of pseudomonads. Then again, restricted growth due to nutrient limitation has long been known to favour secondary metabolism possibly as a means to stay competitive in the environment (Haas & Défago, 2005) . Because biocontrol bacteria are often forced to survive under nutrient-depleted conditions, understanding the impact of the SR on secondary metabolism is essential since this directly impacts fungal inhibition. The focus of the current study was to elucidate how the SR and the stationary phase sigma factor RpoS affect PA23 antagonism of S. sclerotiorum, as well as production of antibiotics and degradative enzymes. Furthermore, we sought to determine if there is a link between the SR and RpoS in this bacterium.
METHODS
Bacterial strains and growth conditions. All bacterial strains and plasmids used in this study are listed in Table 1 . Escherichia coli and P. chlororaphis PA23 strains were cultured on Lennox Luria-Bertani (LB) agar (Difco) at 37 and 28 uC, respectively. S. sclerotiorum was maintained on Potato Dextrose Agar (PDA; Difco). As required, media were supplemented with the following antibiotics from Research Products International: gentamicin (Gm; 20 mg ml 21 ), tetracycline (Tc; 15 mg ml 21 ), piperacillin (30 mg ml 21 ), rifampicin (Rif; 100 mg ml 21 ) for PA23, and ampicillin (Amp; 100 mg ml 21 ), Gm (15 mg ml 21 ), Tc (15 mg ml
21
) for E. coli.
Nucleic acid manipulation. Standard techniques for purification, cloning and other DNA manipulations were used (Sambrook et al., 1989) . PCR was performed following standard conditions suggested by Invitrogen Life Technologies data sheets supplied with their Taq polymerase.
Sequence analysis and nucleotide accession numbers.
Sequencing was performed at the Centre for Applied Genomics in The Hospital for Sick Children (Toronto, Ontario). Sequence information was analysed with BLASTN and BLASTX databases. The GenBank accession numbers for the sequences of the PA23 relA, spoT and rpoS genes are JF705880, JF705881 and DQ525801, respectively.
Generating PA23 relA, relAspoT and rpoS mutants. All primers and plasmids utilized for the construction of mutant strains are listed in Table 1 . PA23relA was generated as follows. An internal portion of the relA gene from PA23 was amplified using primers relA-KpnIFOR and relA-BamHIREV. The resulting 650 bp fragment was cloned into pCR2.1 (Invitrogen) generating pCRrelA-int. The relA insert was removed by digestion with KpnI and BamHI and cloned into the same sites of pKNOCK-Gm, creating pKNOCK-relA. Allelic exchange was performed through triparental mating among E. coli DH5a lpir (pKNOCK-relA), E. coli DH5a (pRK600) and PA23. Transconjugants were screened on LB agar supplemented with Rif and Gm. To verify the insertion into the PA23 relA gene, the pKNOCK-Gm vector was rescued from the PA23 genome by digestion with HincII. Linearized genomic fragments were subsequently recircularized with T4 DNA ligase (Invitrogen), transformed into E. coli DH5a lpir, and screened on LB agar+Gm. Sequencing of the DNA flanking the pKNOCK-Gm vector confirmed that relA had been interrupted. To generate PA23relAspoT, a 2.7 kb fragment containing the spoT gene of strain PA23 was amplified by PCR using primers spoT-FOR and spoT-REV. The PCR product was cloned into pCR2.1, generating pCRspoT-23. Next, the insert was removed through SacI/XbaI digestion and cloned into the same sites of pEX18Ap, creating pEXspoT. A 2.0 kb SmaI fragment containing the Tc R marker from pFTC1 was cloned into a SmaI site within the spoT gene, forming pEXspoT-Tet. Triparental mating was performed using E. coli DH5a (pEXspoT-Tet), E. coli DH5a (pRK600) and PA23, and transconjugants were screened on LB agar plates supplemented with Tc and Rif. Bacteria that had undergone a double cross-over event were identified by streaking onto LB agar containing sucrose (10 %) and Tc. Southern blot and PCR analysis were used to verify that the spoT gene had successfully been replaced with a mutated copy of the alleles. The rpoS mutant PA23rpoS was created by first excising an internal portion of the rpoS gene from PCR2.1-rpoS using the enzymes BamHI and EcoRV. The resulting 400 bp fragment was then subcloned into the same sites of pKNOCK-Tc, generating pKNOCK-rpoS. Triparental mating of E. coli DH5a lpir (pKNOCK-rpoS), E. coli DH5a (pRK600) and PA23 was performed and the transconjugants obtained were screened on LB agar supplemented with Rif and Tc. To verify disruption of the rpoS gene, the pKNOCK-Tc vector was rescued from the PA23 genome by digestion with BglII. Linearized genomic fragments were recircularized with T4 DNA ligase, transformed into E. coli DH5a lpir, and screened on LB agar supplemented with Tc. Sequencing of the rescue clone, using primers RpoS RC-fwd and RpoS RC-rev, verified that an insertion had occurred in rpoS.
Plasmid construction. For complementing the SR mutants, pUCP22-relA and pUCP22-spoT were created such that the relA and spoT genes were under control of the lac promoter on pUCP22. The PA23 relA gene was amplified by PCR using primers relAtranslFRW and 23relAREV and the 2.8 kb product was cloned into pCR2.1. The resulting plasmid, pCRrelA-23, was digested with EcoRI and BamHI and the insert containing relA was subcloned into the same sites of pUCP22, creating pUCP22-relA. A 2.8 kb PCR product containing the PA23 spoT gene was amplified using primers spoT-23 : newFRW and spoT-23 : newREV and cloned into pCR2.1. The resulting plasmid, pCRspoT-23, was digested with XbaI, the ends were blunted with Klenow (Invitrogen) and then subject to BamHI digestion. The 2.8 kb fragment containing spoT was ligated into the BamHI-SmaI sites of pUCP22 generating pUCP22-spoT. For the relA-lacZ translational fusion, a 650 bp fragment containing the promoter and the first 70 codons of the PA23 relA gene was amplified by PCR using primers relAtransl-FRW and 23newrelA-REV. The product was digested with EcoRI and cloned into the EcoRI and SmaI sites of pSW205 creating the plasmid-borne relA-lacZ translational fusion pSWrelA-23.
(p)ppGpp and relA expression analysis. (p)ppGpp levels were determined as described by Cashel (1994) with the following modifications. Cells were grown overnight in morpholinepropanesulfonic acid (MOPS; Sigma-Aldrich) media at 28 uC followed by a 1 : 100 dilution of the culture in MOPS phosphate-free minimal medium containing 1 mg casamino acids ml 21 (Difco) and 100 mCi 32 P ml 21 (Perkin Elmer). Three 200 ml aliquots of each strain were added to wells of a polystyrene microtitre plate (Costar; Corning) and ; Sigma) was then added to each well and incubated for 2 h. Nucleotides were extracted with an equal volume of cold 13 M formic acid, separated on polyethyleneimine-cellulose chromatography sheets (Sigma) and visualized by autoradiography. The (p)ppGpp analysis was repeated three times. Expression of pSWrelA-23 was monitored in PA23, PA23relA and PA23relAspoT. Strains harbouring the plasmid were grown for 4, 8, 12, 16 and 24 h and then assayed for b-galactosidase activity (Miller, 1972) .
Antifungal assays. To assess the ability of PA23 and its derivatives to inhibit fungal growth in vitro, radial diffusion assays were performed according to Poritsanos et al. (2006) . Five replicates were analysed for each strain and the experiments were repeated three times.
Quantitative analysis of PHZ. Overnight cultures of PA23 and the SR mutants were grown in M9 minimal media supplemented with 1 mM MgSO 4 and 0.2 % glucose, and subjected to PHZ extraction as described by Selin et al. (2010) . Samples were analysed in triplicate and the experiment was repeated twice.
HPLC analysis of PRN. The amount of PRN produced by PA23 and its derivatives was quantified by HPLC as described by Selin et al. (2010) with the following modifications. Strains were grown in 100 ml M9 minimal media+1 mM MgSO 4 +0.2 % glucose for 5 days. Toluene was added to the culture supernatants as an internal control. Peaks corresponding to toluene and PRN were analysed by UV absorption at 225 nm using a Varian 335 diode array detector. Samples were analysed in duplicate and the experiment was repeated twice.
HCN analysis. Qualitative determination of HCN production was performed using Cyantesmo paper (Machery-Nagel). Samples were analysed in triplicate and the experiments were repeated three times.
Protease production. Cultures were grown in M9 minimal media supplemented with 1 mM MgSO 4 , 0.2 % glucose and 1.5 % skimmed milk (Difco) for 5 days at 28 uC to induce protease production. A 200 ml aliquot of cell-free supernatant was analysed for protease activity in a 0.65 % solution of casein at 28 uC for 10 min. Tyrosine, which is released upon the hydrolysis of casein by the protease enzyme, is able to react with the Folin-Ciocalteu reagent (Sigma) to produce a blue-coloured chromophore (Cupp-Enyard, 2008) . This chromophore was measured spectrophotometrically at 660 nm. To determine the amount of tyrosine liberated, a standard curve was generated using pure tyrosine at the following concentrations (mM): 0.055, 0.111, 0.221, 0.0442 and 0.553. Each strain was assayed in triplicate and experiments were performed three times.
Lipase production. Lipase assays were performed according to Winkler & Stuckmann (1979) . Briefly, strains were grown in M9 minimal media (Difco) supplemented with 1 mM MgSO 4 , 0.2 % glucose and 0.2 % Tween 20 (Fisher Scientific) at 28 uC for 24 h with aeration. After an additional 96 h of static growth, cell-free supernatant was analysed for lipase activity. A 200 ml aliquot of supernatant was diluted with 2.4 ml of a solution consisting of 30 mg p-nitrophenylpalmitate (Sigma) dissolved in 10 ml 2-propanol and 90 ml 0.5 M Sorensen phosphate buffer supplemented with 207 mg sodium deoxycholate (Sigma) and 100 mg gum arabic (Sigma). After incubation with the supernatant for 30 min at 28 uC, the absorbance was measured at 410 nm. One enzyme unit was defined as the liberation of 1 nmol p-nitrophenyl ml 21 min
. Each strain was assayed in triplicate and experiments were performed three times.
Analysis of transcriptional fusions. The activity of the plasmidborne prnA-, phzA-, and rpoS-lacZ transcriptional fusions was monitored in PA23 and the SR mutants. Strains harbouring the pLP170 derivatives were grown for 4, 8, 12, 16 and 24 h prior to analysis of b-galactosidase activity (Miller, 1972) .
RpoS expression. In order to assess RpoS protein levels, SDS-PAGE and Western blot analysis were performed. Strains were grown in 3 ml M9 minimal media supplemented with 0.2 % glucose and 1 mM MgSO 4 at 28 uC. After 24 h growth, the cultures had reached OD 600
1.3 and were subsequently diluted to OD 600 1.0 to ensure that an equal number of cells were analysed. Cells were pelleted, resuspended in sample buffer [63 mmol Tris/HCl l 21 pH 6.8, 2 % SDS, 25 % (v/v) glycerol, 0.01 % bromophenol blue] containing 1 % b-mercaptoethanol and then boiled for 3 min. A 100 mg protein sample, determined by the Bradford assay (Bradford, 1976) , was loaded and separated on a 12 % SDS-PAGE gel. Blots were incubated with RpoS-specific antibodies (Institute of Molecular and Cellular Bio-sciences, University of Tokyo, Tokyo, Japan), followed by alkaline phosphatase-conjugated goat anti-rabbit antiserum (Sigma). Antibodies were detected using the colorimetric detection reagent NBT/BCIP (Roche Diagnostics). RpoS was quantified with a Fluorochem 2000 Phosphoimager using Fluorochem Stand-Alone software, version 2.0. The Western blot analysis was repeated twice with similar findings.
Statistical analysis. An unpaired Student's t-test was used for statistical analysis of AF, protease and lipase activity.
RESULTS

PA23 SR mutant generation and (p)ppGpp analysis
To assess the impact of the SR on AF activity, relA and relAspoT mutants of strain PA23 were generated. Primers designed from the P. aeruginosa PAO1 relA and spoT sequences enabled us to amplify these genes from PA23. The PA23relA and spoT genes were 95 and 92 % identical to those of P. fluorescens Pf0-1 (CP000094.2) and P. fluorescens Pf-5 (CP000076.1), respectively. The first mutant, PA23relA, was created through plasmid insertion. Rescue cloning and sequence analysis of the DNA flanking the pKNOCK-Gm vector confirmed disruption of the wildtype allele (data not shown). To generate a relAspoT double mutant, the spoT gene of PA23relA was mutated through allelic exchange. PCR and Southern blot analysis verified that in PA23relAspoT, spoT had been replaced with a mutated copy of the allele (data not shown). We were unable to generate a PA23 spoT single mutant, leading us to believe that in a relA + background, spoT is required for cell viability, similar to reports for other bacteria (Potrykus & Cashel, 2008) .
To determine if disruption of the aforementioned genes affected (p)ppGpp production, bacteria were grown in the presence of DL-serine hydroxymate, a potent inducer of the SR. As shown in Fig. 1 , PA23 was able to produce both ppGpp and pppGpp (lane 2); however, (p)ppGpp was undetectable in the SR mutants (lanes 3 and 4) . Production of these nucleotides was restored in PA23relA and PA23relAspoT when the relA gene was added in trans (Fig. 1, lanes 5 and 6) . The presence of spoT in multicopy, however, did not restore (p)ppGpp production in the SR mutants (data not shown).
The SR affects PA23-mediated antagonism of S. sclerotiorum by regulating PRN, lipase and protease activity Next, we assessed the ability of the SR mutants to antagonize S. sclerotiorum in vitro. When grown in M9 minimal media, both PA23relA and PA23relAspoT exhibited a 1.3-fold increase in AF activity compared with the wild type ( Table 2 ). The presence of pUCP22-relA in the SR mutants restored the AF activity to that of the wild type (Table 2) . Conversely, pUCP22-spoT did not alter fungal antagonism by the mutants ( Table 2 ). As production of secondary metabolites occurs at the transition between the logarithmic and stationary phases of growth, it is important to note that there were no differences in the growth rate among all strains (data not shown).
PA23 produces a number of AF factors including PRN, PHZ and HCN. Of these, PRN was found to be most important for PA23 antagonism of S. sclerotiorum (Selin et al., 2010) . Therefore, we explored the possibility that the enhanced AF activity demonstrated by the ppGpp-deficient strains was the result of increased antibiotic production. Expression of plasmid-borne phzA-lacZ (PHZ) and prnAlacZ (PRN) transcriptional fusions was monitored in PA23, PA23relA and PA23relAspoT. As shown in Fig. 2(a) , phzAlacZ activity was similar for all three strains. Expression of the prnA fusion, on the other hand, was elevated in PA23relA and PA23relAspoT (Fig. 2b) . When we looked at PHZ, PRN and HCN production, we observed the same trend. There were no differences in terms of total PHZ produced and all three strains tested positive for HCN production (Table 2 ). In contrast, the total amount of PRN in the cell-free supernatants of the SR mutants was 2.5-fold greater than in PA23 (Table 2) . Mobilization of pUCP22-relA into PA23relA and PA23relAspoT reduced PRN production to wild-type levels (Table 2) .
Next, we quantified the amount of lipase and protease in cell-free supernatants of PA23 and the SR mutants. Lipase activity was increased 1.2-fold in PA23relA and 1.3-fold in PA23relAspoT (Table 2) . Similarly, protease activity was elevated 1.75-and 2.3-fold in the single and double mutants, respectively ( Table 2) . Addition of pUCP22-relA restored lipase and protease activity to wild-type levels ( Table 2 ).
The SR exerts its effects on PA23-mediated fungal antagonism through RpoS
In both E. coli and P. aeruginosa, rpoS expression is upregulated during the SR (van Delden et al., 2001; Erickson et al., 2004; Potrykus & Cashel, 2008) . To determine if rpoS forms part of the PA23 SR regulon, expression of a plasmid-borne rpoS-lacZ transcriptional fusion was monitored in the SR mutants. As shown in Fig.  3(a) , rpoS transcription was dramatically reduced in the mutants during both the exponential and stationary phases of growth. Furthermore, there was markedly less RpoS protein produced by the SR mutants (Fig. 3b, c) , and addition of relA or rpoS in trans restored RpoS levels to those of the wild type. To address whether decreased rpoS expression was responsible for the phenotypic changes observed for the SR mutants, strains harbouring pUCP22-rpoS were examined for production of AF factors. The presence of rpoS constitutively expressed from the lac promoter was able to fully complement the relA and relAspoT mutants with respect to AF, protease and lipase activity and PRN production ( Table 2) . As expected, no RpoS protein was detected in PA23rpoS; however, production of this sigma factor was restored upon addition of pUCP22-rpoS in trans (Fig. 3) . Therefore, it appears that the effects of the SR on PA23-mediated antagonism are mediated primarily through RpoS.
RpoS regulates PRN, lipase and protease activity as well as PHZ biosynthesis
In various Pseudomonas species, RpoS has been found to be involved in antibiotic production (Sarniguet et al., 1995; Heeb et al., 2005; Ge et al., 2006; Girard et al., 2006a; Park et al., 2011) . The fact that rpoS transcription was markedly decreased in the SR mutants and the wild-type phenotype was restored by providing rpoS in trans led us to investigate the role of RpoS in PA23 antagonism. Generation and characterization of an rpoS mutant, PA23rpoS, revealed enhanced AF activity and PRN production (Table 2) as well as increased prnA-lacZ expression (Fig. 2b) , similar to the observations for the SR mutants. Conversely, we found that both phzA-lacZ expression (Fig. 2a) and PHZ levels were reduced in the rpoS mutant compared with the wild-type (Table 2 ). No differences in HCN production (Table 2) or growth rate were observed between PA23 and PA23rpoS Fig. 1. (p) ppGpp analysis of Pseudomonas chlororaphis PA23 and its SR derivatives after induction with serine hydroxymate. Cells were labelled with 32 P and nucleotides were extracted and separated by thin layer chromatography. Lanes: 1, PAO1; 2, PA23; 3, PA23relA; 4, PA23relAspoT; 5, PA23relA (pUCP22-relA); 6, PA23relAspoT (pUCP22-relA).
Stringent response reduces antifungal activity
(data not shown). Next, we determined whether the rpoS mutation affects extracellular enzyme production. More than a twofold increase in both protease and lipase activity was observed for PA23rpoS compared with the wild-type ( Table 2 ). The rpoS mutant harbouring pUCP22-rpoS exhibited wild-type AF, protease and lipase activity as well as PRN and PHZ production (Table 2) . Therefore, with the exception of PHZ expression, the phenotype of the rpoS mutant resembles that of the SR mutants.
RelA is negatively regulated by (p)ppGpp
When expression of a plasmid-borne relA-lacZ translational fusion was monitored in PA23 and the SR mutants, all three strains showed maximal relA expression at stationary phase (16 h growth) followed by a sharp decline in expression at 24 h. However at 16 h, PA23relA and PA23relAspoT exhibited a twofold or greater increase in relA expression compared with the wild-type (Fig. 4) . Thus it appears that the SR negatively regulates relA in PA23.
DISCUSSION
When applied as a foliar spray, P. chlororaphis strain PA23 is an effective biocontrol agent capable of inhibiting sclerotinia stem rot of canola (Savchuk & Fernando, 2004; Poritsanos et al., 2006) . Because nutrients are scarce in the phyllosphere (Lindow & Brandl, 2003) , we were interested in understanding how the SR affects the AF properties of this bacterium. PA23 relA and relAspoT derivatives were created that showed reduced (p)ppGpp accumulation and enhanced AF activity under nutrientlimiting conditions (Table 2) . Thus it appears that the SR negatively affects the antagonistic potential of this organism. We discovered that lipase, protease and PRN production was increased in the SR mutants; conversely PHZ production remained unchanged (Table 2) . Consistent with the antibiotic levels, prnA-lacZ and phzA-lacZ fusion analysis showed elevated expression of prnA but not phzA in the SR mutant background (Fig. 2) . Thus, we believe that the increase in PA23relA-and PA23relAspoT-mediated antagonism results from elevated production of PRN, and possibly protease and lipase, by these strains.
With the exception of Pseudomonas sp. MIS38, very little is known about the impact of the SR on fungal antagonism by pseudomonads. A spoT mutant of MIS38 exhibited increased (p)ppGpp and reduced arthrofactin levels, suggesting that the SR negatively regulates production of this antibiotic (Washio et al., 2010) , similar to what we observed with PRN. As PHZ production remained unchanged, we conclude that not all of the AF compounds produced by PA23 are regulated by the SR. In a similar fashion, the SR differentially affects antibiotic production by Streptomyces species. Depending upon the strain in question, the antibiotics produced and the growth medium employed, the SR was found to influence antibiotic expression positively, negatively or not at all. For instance, a Streptomyces clavuligerus relA mutant produced elevated levels of clavulanic acid and cephamycin C (GomezEscribano et al., 2008) , while a relA deficiency in Streptomyces coelicolor ATCC 27064 abolished cephamycin C production (Jin et al., 2004) . This same mutation in Streptomyces coelicolor strain A3(2) had little effect on actinorhodin and undecylprodigiosin expression (Sun et al., 2001) . From these examples and our own findings, it is evident that a great deal of variability exists. So far, we have been unable to define a role for SpoT in PA23 secondary metabolism. The phenotype of our relAspoT double mutant was remarkably similar to the relA mutant, and constitutive expression of spoT in PA23relAspoT imparted no discernible changes. But we cannot rule out the possibility that under different conditions, SpoT plays a more dominant role in PA23 secondary metabolism.
In E. coli and P. aeruginosa, the SR positively regulates expression of RpoS (van Delden et al., 2001; Erickson et al., 2004; Potrykus & Cashel, 2008) . In much the same way, we observed a fivefold decrease in rpoS transcription in the SR mutants compared with PA23 (Fig. 3a) . This dramatic decrease in rpoS expression led us to speculate that the SR mutant phenotype might result from reduced levels of RpoS. Indeed, when rpoS was added in trans, PRN production, as well as AF, protease and lipase activity were restored to that of the wild type (Table 2) . Moreover, the SR mutants containing multicopy relA exhibited RpoS levels equal to or higher than those of PA23 (Fig. 3b, c) . Collectively, these findings indicate that the effect of the SR on PA23 AF activity is mediated primarily through RpoS.
RpoS has been implicated in the production of antibiotics in several biocontrol pseudomonads (Sarniguet et al., 1995; Heeb et al., 2005; Ge et al., 2006; Girard et al., 2006a; Park et al., 2011) . Depending on the strain in question and the antibiotic produced, RpoS may have a positive (Sarniguet et al. 1995; Whistler et al., 1998; Ge et al., 2006; Girard et al., 2006a; Park et al., 2011) , negative (Sarniguet et al. 1995; Whistler et al., 1998; Heeb et al., 2005; Ge et al., 2006) or no (Heeb et al., 2005) effect on antibiotic expression. To assess the role of this sigma factor in PA23-mediated fungal antagonism, an rpoS mutant was generated. As was demonstrated by the SR mutants, PA23rpoS exhibited increased growth inhibition of S. sclerotiorum in vitro presumably through enhanced production of the same metabolites (Table 2 ). The discovery that RpoS negatively regulates PRN differs from the situation that has been observed in P. fluorescens Pf-5 where an rpoS mutation abolished PRN production (Sarniguet et al., 1995; Whistler et al., 1998) . At the same time, wild-type and rpoS 2 strains of both PA23 and Pf-5 were found to produce HCN and protease. The reason for the discrepancy in RpoS-mediated control over PRN expression is unclear. As these two bacteria produce a different spectrum of secondary metabolites, it is possible that upregulation of one metabolite causes downregulation of another, which has been reported previously (Schnider-Keel et al., 2000; Baehler et al., 2005) . Alternatively, RpoS may be affecting PRN expression indirectly through regulatory elements which differ between these two bacteria.
Where PA23rpoS differs from PA23relA and PA23relAspoT is in the expression of PHZ. While the SR mutants are able to produce PHZ despite having low amounts of RpoS (Fig.  3b, c) , the rpoS mutant showed an eightfold reduction in PHZ levels and significantly reduced phzA transcription (Fig. 2a) . Perhaps the residual level of RpoS in the SR mutants enables wild-type PHZ production under the conditions tested. It is important to note that previous studies have shown PHZ regulation in P. chlororaphis to be complex. In P. chlororaphis 30-84, for example, a repressor called RpeA has been identified that decreases PHZ biosynthesis under minimal media conditions (Whistler & Pierson, 2003) . Furthermore, an RpoS-dependent protein called Pip was found to induce phenazine-1-carboxamide expression in P. chlororaphis 1391 (Girard et al., 2006b) . Homologues of rpeA and pip have not yet been identified in PA23. If these regulators are present, their characterization may help to clarify the connection between nutrient status and the regulatory network governing PHZ expression in this bacterium.
In summary, we have established that the SR exerts a negative effect on PA23 AF activity in vitro, mediated by increased RpoS expression. Because manufacture of AF factors is energetically costly, it is logical for bacteria to reduce production of these compounds when nutrients are scarce. Whether the SR mutants would exhibit enhanced biocontrol in planta has yet to be established. Decreased RpoS levels would likely render these strains more sensitive to oxidative stress, heat shock and high osmolarity conditions. Such changes could decrease the environmental fitness of the bacteria, possibly diminishing their biocontrol potential. Future work will be directed at understanding how the SR affects PA23 colonization and antagonism in different environments. Lanes: 1, PA23 (pUCP22); 2, PA23relA (pUCP22); 3, PA23relAspoT (pUCP22); 4, PA23relA (pUCP22-relA); 5, PA23relAspoT (pUCP22-relA); 6, PA23relA (pUCP22-rpoS); 7, PA23relAspoT (pUCP22-rpoS); 8, PA23rpoS (pUCP22); 9, PA23rpoS (pUCP22-rpoS). (c) The RpoS content in each lane was estimated by analysing Western blots with a phosphoimager. The Western blot analysis was performed twice and a representative dataset is shown. Fig. 4 . RelA exhibits negative autoregulation. Expression of relA was monitored in PA23 (e), PA23relA (h) and PA23relAspoT (g). All strains harboured the relA-lacZ reporter plasmid pSWrelA-23. Error bars indicate SD.
